-
1 Comment
Olympus Corporation is currently in a long term uptrend where the price is trading 3.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
Olympus Corporation's total revenue sank by 4.3% to $197B since the same quarter in the previous year.
Its net income has increased by 5.4% to $24B since the same quarter in the previous year.
Finally, its free cash flow grew by 78.1% to $42B since the same quarter in the previous year.
Based on the above factors, Olympus Corporation gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| ISIN | JP3201200007 |
| Exchange | F |
| CurrencyCode | EUR |
| Market Cap | 12B |
|---|---|
| PE Ratio | 22.83 |
| Beta | 0.34 |
| Dividend Yield | 1.7% |
| Target Price | None |
Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platforms, and AI insights and computer-aided detection/diagnosis products; reprocessing products, such as endoscope reprocessors, chemicals, accessories, and peripherals; and medical services, which include repair center services. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat; and gastroenterology devices and gynecology products. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OLY1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025